Staphylococcus aureus biofilms: Properties, regulation and roles in human disease

Virulence

Volumn 2, Issue 5, 2011, Pages 445-459

  Archer, Nathan K ^a,b   Mazaitis, Mark J ^c   William Costerton, J ^d   Leid, Jeff G ^e   Powers, Mary Elizabeth ^f   Shirtliff, Mark E ^a,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^e NORTHERN ARIZONA UNIVERSITY   (United States)

^f UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Biofilms; Host response; MRSA; Pathogenesis; Staphylococcus aureus; Therapy; Vaccine

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL DNA; IMMUNOGLOBULIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SMAD ANCHOR FOR RECEPTOR ACTIVATION; TOBRAMYCIN; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENETICS; ENDOCARDITIS; EXTRACELLULAR MATRIX; EYE INFECTION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; OSTEOMYELITIS; PERIIMPLANTITIS; PERIODONTITIS; PHENOTYPE; REVIEW; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS BIOFILMS; STAPHYLOCOCCUS INFECTION; UNSPECIFIED SIDE EFFECT; WOUND INFECTION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 80053910254     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.5.17724     Document Type: Review

References (155)

1. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93; PMID:11932229; DOI:10.1128/CMR.15.2.167-93.2002.
2. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995; 49:711-45; PMID:8561477; DOI:10.1146/annurev.mi.49.100195.003431.
3. Kristian SA, Golda T, Ferracin F, Cramton SE, Neumeister B, Peschel A, et al. The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog 2004; 36:237-45; PMID:15043859; DOI:10.1016/j.micpath.2003.12.004.
4. Rani SA, Pitts B, Beyenal H, Veluchamy RA, Lewandowski Z, Davison WM, et al. Spatial patterns of DNA replication, protein synthesis and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol 2007; 189:4223-33; PMID:17337582; DOI:10.1128/JB.00107-07.
5. Brady RA, Leid JG, Kofonow J, Costerton JW, Shirtliff ME. Immunoglobulins to surface-associated biofilm immunogens provide a novel means of vis ualization of methicillin-resistant Staphylococcus aureus biofilms. Appl Environ Microbiol 2007; 73:6612-9; PMID:17720840; DOI:10.1128/AEM.00855-07.
6. Beveridge TJ, Makin SA, Kadurugamuwa JL, Li Z. Interactions between biofilms and the environment. FEMS Microbiol Rev 1997; 20:291-303; PMID:9299708; DOI:10.1111/j.1574-6976.1997. tb00315.x.
7. Lewis K. Persister cells. Annu Rev Microbiol 2010; 64:357-72; PMID:20528688; DOI:10.1146/annurev. micro.112408.134306.
8. Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001; 183:6746- 51; PMID:11698361; DOI:10.1128/JB.183.23.6746-51.2001.
9. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005; 70:267-74; PMID:15807669; DOI:10.1007/s10541-005-0111-6.
10. Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology 2000; 146:547-9; PMID:10746758.
11. De Beer D, Srinivasan R, Stewart PS. Direct measurement of chlorine penetration into biofilms during disinfection. Appl Environ Microbiol 1994; 60:4339-44; PMID:7811074.
12. Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2010; 65:1955-8; PMID:20615927; DOI:10.1093/jac/dkq257.
13. Boyd A, Chakrabarty AM. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 1994; 60:2355-9; PMID:8074516.
14. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002; 184:1140-54; PMID:11807075;DOI:10.1128/jb.184.4.1140-54.2002.
15. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10:505-20.PMID:9227864.
16. Dall'Antonia M, Coen PG, Wilks M, Whiley A, Millar M. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J Hosp Infect 2005; 61:62-7.PMID:15893854; DOI:10.1016/j.jhin.2005.01.008.
17. Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, et al. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 2004; 186:4665-84; PMID:15231800; DOI:10.1128/JB.186.14.4665-84.2004.
18. Fitzpatrick F, Humphreys H, O'Gara JP. The genetics of staphylococcal biofilm formation-will a greater understanding of pathogenesis lead to better management of device-related infection? Clin Microbiol Infect 2005; 11:967-73.PMID:16307550; DOI:10.1111/j.1469-0691.2005.01274.x.
19. Hussain M, Wilcox MH, White PJ. The slime of coagulase- negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol Rev 1993; 10:191-207.PMID:8318256.
20. Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996; 178:175-83. PMID:8550413.
21. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67:5427-33.PMID:10496925.
22. Cramton SE, Ulrich M, Gotz F, Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 2001; 69:4079-85.PMID:11349079; DOI:10.1128/IAI.69.6.4079-85.2001.
23. Ulrich M, Bastian M, Cramton SE, Ziegler K, Pragman AA, Bragonzi A, et al. The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions. Mol Microbiol 2007; 65:1276-87.PMID:17697253.DOI:10.1111/j.1365-2958.2007.05863.x.
24. Conlon KM, Humphreys H, O'Gara JP. icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J Bacteriol 2002; 184:4400-8.PMID:12142410; DOI:10.1128/ JB.184.16.4400-8.2002.
25. Kiem S, Oh WS, Peck KR, Lee NY, Lee JY, Song JH, et al. Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J Korean Med Sci 2004; 19:779-82.PMID:15608385; DOI:10.3346/jkms.2004.19.6.779.
26. Jefferson KK, Pier DB, Goldmann DA, Pier GB. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol 2004; 186:2449-56.PMID:15060048; DOI:10.1128/JB.186.8.2449-56.2004.
27. Jefferson KK, Cramton SE, Gotz F, Pier GB. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol 2003; 48:889-99.PMID:12753184; DOI:10.1046/j.1365-2958.2003.03482.x.
28. Cue D, Lei MG, Luong TT, Kuechenmeister L, Dunman PM, O'Donnell S, et al. Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of icaADBC. J Bacteriol 2009; 191:6363-73.PMID:19684134; DOI:10.1128/ JB.00913-09.
29. Pamp SJ, Frees D, Engelmann S, Hecker M, Ingmer H. Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus. J Bacteriol 2006; 188:4861-70.PMID:16788195; DOI:10.1128/ JB.00194-06.
30. Toledo-Arana A, Merino N, Vergara-Irigaray M, Debarbouille M, Penades JR, Lasa I. Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system. J Bacteriol 2005; 187:5318-29.PMID:16030226; DOI:10.1128/JB.187.15.5318-29.2005.
31. Francois P, Tu Quoc PH, Bisognano C, Kelley WL, Lew DP, Schrenzel J, et al. Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol Med Microbiol 2003; 35:135-40.PMID:12628549; DOI:10.1016/S0928-8244(02)00463-7.
32. Fitzpatrick F, Humphreys H, O'Gara JP. Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol 2005; 43:1973-6.PMID:15815035; DOI:10.1128/JCM.43.4.1973- 6.2005.
33. O'Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 2007; 45:1379-88.PMID:17329452; DOI:10.1128/JCM.02280-06.
34. Merino N, Toledo-Arana A, Vergara-Irigaray M, Valle J, Solano C, Calvo E, et al. Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol 2009; 191:832-43.PMID:19047354; DOI:10.1128/JB.01222-08.
35. Houston P, Rowe SE, Pozzi C, Waters EM, O'Gara JP. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun 2011; 79:1153-65.PMID:21189325; DOI:10.1128/IAI.00364-10.
36. Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIA-independent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. Int J Med Microbiol 2007; 297:117-22.PMID:17292669; DOI:10.1016/j.ijmm.2006.12.001.
37. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007; 28:1711-20.PMID:17187854; DOI:10.1016/j.biomaterials.2006.11.046.
38. Lasa I, Penades JR. Bap: a family of surface proteins involved in biofilm formation. Res Microbiol 2006; 157:99-107.PMID:16427771; DOI:10.1016/j.resmic. 2005.11.003.
39. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002; 295:1487.PMID:11859186; DOI:10.1126/science.295.5559.1487.
40. Steinberger RE, Holden PA. Extracellular DNA in single- and multiple-species unsaturated biofilms. Appl Environ Microbiol 2005; 71:5404-10.PMID:16151131; DOI:10.1128/AEM.71.9.5404-10.2005.
41. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 2006; 59:1114-28.PMID:16430688; DOI:10.1111/j.1365-2958.2005.05008.x.
42. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918-51.PMID:14555458; DOI:10.1164/rccm.200304- 505SO.
43. Eckhart L, Fischer H, Barken KB, Tolker-Nielsen T, Tschachler E. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. Br J Dermatol 2007; 156:1342-5.PMID:17459041; DOI:10.1111/j.1365-2133.2007.07886.x.
44. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA 2007; 104:8113-8.PMID:17452642; DOI:10.1073/ pnas.0610226104.
45. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 2009; 4:5822.PMID:19513119; DOI:10.1371/journal. pone.0005822.
46. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 2006; 74:3415-26.PMID:16714572; DOI:10.1128/ IAI.00392-06.
47. Resch A, Fehrenbacher B, Eisele K, Schaller M, Gotz F. Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett 2005; 252:89-96. PMID:16213676; DOI:10.1016/j.femsle.2005.08.048.
48. Fournier B, Klier A, Rapoport G. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol 2001; 41:247-61. PMID:11454217; DOI:10.1046/ j.1365-2958.2001.02515.x.
49. Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, Penades JR, et al. SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 2003; 48:1075-87. PMID:12753197; DOI:10.1046/j.1365-2958.2003.03493.x.
50. Beenken KE, Blevins JS, Smeltzer MS. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun 2003; 71:4206-11.PMID:12819120; DOI:10.1128/IAI.71.7.4206-11.2003.
51. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS. Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS ONE 2008; 3:3361. PMID:18846215; DOI:10.1371/ journal.pone.0003361.
52. Cheung AL, Projan SJ. Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr. J Bacteriol 1994; 176:4168-72.PMID:8021198.
53. Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, et al. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS ONE 2010; 5:10790.PMID:20520723; DOI:10.1371/journal.pone.0010790.
54. Chan WC, Coyle BJ, Williams P. Virulence regulation and quorum sensing in staphylococcal infections: competitive AgrC antagonists as quorum sensing inhibitors. J Med Chem 2004; 47:4633-41.PMID:15341477; DOI:10.1021/jm0400754.
55. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog 2008; 4:1000052.PMID:18437240; DOI:10.1371/journal. ppat.1000052.
56. Lauderdale KJ, Boles BR, Cheung AL, Horswill AR. Interconnections between SigmaB, agr and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun 2009; 77:1623-35.PMID:19188357; DOI:10.1128/IAI.01036-08.
57. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol 2006; 296:133-9.PMID:16487744; DOI:10.1016/j.ijmm.2006.01.042.
58. Pané-Farré J, Jonas B, Forstner K, Engelmann S, Hecker M. The sigmaB regulon in Staphylococcus aureus and its regulation. Int J Med Microbiol 2006; 296:237-58.PMID:16644280; DOI:10.1016/j.ijmm.2005.11.011.
59. Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, et al. Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus. Infect Immun 1999; 67:3667-9. PMID:10377157.
60. B regulon influences internalization of Staphylococcus aureus by osteoblasts. Infect Immun 2003; 71:4167-70. PMID:12819110; DOI:10.1128/IAI.71.7.4167-70.2003.
61. Kullik I, Giachino P. The alternative sigma factor sigmaB in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock. Arch Microbiol 1997; 167:151-9.PMID:9042755; DOI:10.1007/s002030050428.
62. Rachid S, Ohlsen K, Wallner U, Hacker J, Hecker M, Ziebuhr W. Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol 2000; 182:6824-6.PMID:11073930; DOI:10.1128/ JB.182.23.6824-6.2000.
63. Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, et al. Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 2006; 152:3075-90.PMID:17005987; DOI:10.1099/mic.0.29033-0.
64. Resch A, Leicht S, Saric M, Pasztor L, Jakob A, Gotz F, et al. Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics 2006; 6:1867-77.PMID:16470655; DOI:10.1002/pmic.200500531.
65. Dunman PM, Murphy E, Haney S, Palacios D, Tucker- Kellogg G, Wu S, et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 2001; 183:7341-53.PMID:11717293; DOI:10.1128/JB.183.24.7341- 53.2001.
66. Wenzel RP, Edmond MB. The impact of hospitalacquired bloodstream infections. Emerg Infect Dis 2001; 7:174-7.PMID:11294700; DOI:10.3201/ eid0702.010203.
67. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999; 5:9-17.PMID:10081667; DOI:10.3201/eid0501.990102.
68. Jones SM, Morgan M, Humphrey TJ, Lappin-Scott H. Effect of vancomycin and rifampicin on meticillinresistant Staphylococcus aureus biofilms. Lancet 2001; 357:40-1.PMID:11197363; DOI:10.1016/S0140-6736(00)03572-8.
69. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364:369-79.PMID:15276398; DOI:10.1016/S0140-6736(04)16727-5.
70. Ziran BH. Osteomyelitis. J Trauma 2007; 62:59-60.PMID:17556977; DOI:10.1097/ TA.0b013e318065abbd.
71. Anwar S, Prince LR, Foster SJ, Whyte MK, Sabroe I. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol 2009; 157:216-24.PMID:19604261; DOI:10.1111/j.1365-2249.2009.03950.x.
72. Akiyama H, Torigoe R, Arata J. Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. J Dermatol Sci 1993; 6:247-57. PMID:8136322; DOI:10.1016/0923-1811(93)90046-R.
73. Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother 2009; 53:1142-8.PMID:19075065; DOI:10.1128/AAC.00775-08.
74. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28:1062-8.PMID:16353112.
75. Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, et al. Fibronectin, fibrinogen and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158:693-701.PMID:3171224; DOI:10.1093/infdis/158.4.693.
76. Heitz-Mayfield LJ, Lang NP. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000 2010; 53:167-81.PMID:20403112; DOI:10.1111/j.1600-0757.2010.00348.x.
77. Cuesta AI, Jewtuchowicz V, Brusca MI, Nastri ML, Rosa AC. Prevalence of Staphylococcus spp. and Candida spp. in the oral cavity and periodontal pockets of periodontal disease patients. Acta Odontol Latinoam 2010; 23:20-6.PMID:20645638.
78. Gjødsbøl K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006; 3:225-31.PMID:16984578; DOI:10.1111/j.1742-481X.2006.00159.x.
79. Hansson C, Hoborn J, Moller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995; 75:24-30.PMID:7747531.
80. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16:23-9.PMID:18211576; DOI:10.1111/j.1524-475X.2007.00303.x.
81. Bowling FL, Jude EB, Boulton AJ. MRSA and diabetic foot wounds: contaminating or infecting organisms? Curr Diab Rep 2009; 9:440-4.PMID:19954689; DOI:10.1007/s11892-009-0072-z.
82. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009; 17:354-9.PMID:19660043; DOI:10.1111/j.1524- 475X.2009.00489.x.
83. Foreman A, Wormald PJ. Different biofilms, different disease? A clinical outcomes study. Laryngoscope 2010; 120:1701-6.PMID:20641074; DOI:10.1002/ lary.21024.
84. Ferguson BJ, Stolz DB. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 2005; 19:452-7.PMID:16270598.
85. Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 2008; 22:1-6.PMID:18284851; DOI:10.2500/ajr.2008.22.3119.
86. Stephenson MF, Mfuna L, Dowd SE, Wolcott RD, Barbeau J, Poisson M, et al. Molecular characterization of the polymicrobial flora in chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2010; 39:182-7.PMID:20211106.
87. Røder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999; 159:462-9.PMID:10074954; DOI:10.1001/archinte.159.5.462.
88. Murugan K, Usha M, Malathi P, Al-Sohaibani AS, Chandrasekaran M. Biofilm forming multi drug resistant Staphylococcus spp. among patients with conjunctivitis. Pol J Microbiol 2010; 59:233-9.PMID:21466040.
89. Leid JG, Costerton JW, Shirtliff ME, Gilmore MS, Engelbert M. Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. DNA Cell Biol 2002; 21:405-13.PMID:12167243; DOI:10.1089/10445490260099692.
90. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol 2010; 59:493-503.PMID:20608978.
91. Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol 2004; 12:317-24.PMID:15223059; DOI:10.1016/j. tim.2004.05.008.
92. Prabhakara R, Harro JM, Leid JG, Harris M, Shirtliff ME. Murine Immune Response to a Chronic Staphylococcus aureus Biofilm Infection. Infect Immun 2011; 79:1789-96. PMID:21282411; DOI:10.1128/ IAI.01386-10.
93. Muschel LH, Jackson JE. The reactivity of serum against protoplasts and spheroplasts. J Immunol 1966;97:46-51.PMID:4958551.
94. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005; 6:920-7.PMID:16086019; DOI:10.1038/ni1235.
95. Kobayashi SD, DeLeo FR. Role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip Rev Syst Biol Med 2009; 1:309-33.PMID:20836000; DOI:10.1002/wsbm.32.
96. Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate and respond to Staphylococcus aureus biofilms. Infect Immun 2002; 70:6339-45.PMID:12379713; DOI:10.1128/ IAI.70.11.6339-45.2002.
97. Guenther F, Stroh P, Wagner C, Obst U, Hansch GM. Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. Int J Artif Organs 2009; 32:565-73.PMID:19856266.
98. Meyle E, Stroh P, Gunther F, Hoppy-Tichy T, Wagner C, Hansch GM. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release and degranulation. Int J Artif Organs 2010; 33:608-20. PMID:20890882.
99. Stroh P, Gunther F, Meyle E, Prior B, Wagner C, Hansch GM. Host defence against Staphylococcus aureus biofilms by polymorphonuclear neutrophils: oxygen radical production but not phagocytosis depends on opsonisation with immunoglobulin G. Immunobiology 2011; 216:351-7. PMID:20850891; DOI:10.1016/j.imbio.2010.07.009.
100. McLaughlin RA, Hoogewerf AJ. Interleukin-1betainduced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures. Microb Pathog 2006; 41:67-79. PMID:16769197; DOI:10.1016/j.micpath.2006.04.005.
101. th ASM Conference on Biofilms. Cancun, Mexico 2009.
102. NIH NH, Lung and Blood Institiute Research on Microbial Biofilms 2002.
103. O'May GA, Brady RA, Prabhakara R, Leid JG, Calhoun JH, Shirtliff ME, Eds. Osteomyelitis. In Biofilm Infections: New York: Springer 2010.
104. Kim HK, Cheng AG, Kim HY, Missiakas DM, Schneewind O. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med 2010; 207:1863-70.PMID:20713595; DOI:10.1084/jem.20092514.
105. Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 2006; 74:2215-23.PMID:16552052; DOI:10.1128/IAI.74.4.2215-23.2006.
106. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci USA 2006; 103:16942-7.PMID:17075065; DOI:10.1073/pnas.0606863103.
107. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38:1651-71.PMID:15227610; DOI:10.1086/420939.
108. Osmon DR, Berbari EF. Outpatient intravenous antimicrobial therapy for the practicing orthopaedic surgeon. Clin Orthop Relat Res 2002; 80-6.PMID:12360011; DOI:10.1097/00003086-200210000-00013.
109. McKinnon PS, Davis SL. Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases. Eur J Clin Microbiol Infect Dis 2004; 23:271-88.PMID:15015030; DOI:10.1007/ s10096-004-1107-7.
110. Rao N, Ziran BH, Lipsky BA. Treating osteomyelitis: antibiotics and surgery. Plast Reconstr Surg 2011; 127:177-87.PMID:21200289; DOI:10.1097/ PRS.0b013e3182001f0f.
111. Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 2001; 7:589-96.PMID:11737083; DOI:10.1046/j.1198- 743x.2001.00295.x.
112. Andes D, Craig WA. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. [vi.]. Infect Dis Clin North Am 1998; 12:849-60.PMID:9888026; DOI:10.1016/S0891-5520(05)70024-6.
113. Gould IM. VRSA-doomsday superbug or damp squib? Lancet Infect Dis 2010; 10:816-8.PMID:21109164; DOI:10.1016/S1473-3099(10)70259-0.
114. Fraimow HS. Systemic antimicrobial therapy in osteomyelitis. Semin Plast Surg 2009; 23:90-9. PMID:20567731; DOI:10.1055/s-0029-1214161.
115. Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168:805-19.PMID:18443255; DOI:10.1001/archinte.168.8.805.
116. Wahlig H, Dingeldein E. Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 1980; 51:49-56.PMID:7376844; DOI:10.3109/17453678008990768.
117. Klemm K. [Gentamicin-PMMA-beads in treating bone and soft tissue infections (author's transl)]. Zentralbl Chir 1979; 104:934-42.PMID:494865.
118. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother 1996; 40:2675-9.PMID:9124821.
119. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004; 25:4383-91.PMID:15046929; DOI:10.1016/j.biomaterials. 2003.10.078.
120. Boyce BM, Lindsey BA, Clovis NB, Smith ES, Hobbs GR, Hubbard DF, et al. Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis. J Orthop Res 2011; In press.PMID:21815205; DOI:10.1002/jor.21520.
121. Friedman A, Blecher K, Sanchez D, Tuckman-Vernon C, Gialanella P, Friedman JM, et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2011; 2:217-21.PMID:21577055; DOI:10.4161/ viru.2.3.16161.
122. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 2005; 11:211-9.PMID:16258815; DOI:10.1007/s10156-005-0408-9.
123. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101:9786-91.PMID:15213324; DOI:10.1073/pnas.0402521101.
124. Chua K, Seemann T, Harrison PF, Davies JK, Coutts SJ, Chen H, et al. Complete genome sequence of Staphylococcus aureus strain JKD6159, a unique Australian clone of ST93-IV community methicillin- resistant Staphylococcus aureus. J Bacteriol 2010; 192:5556-7.PMID:20729356; DOI:10.1128/ JB.00878-10.
125. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 2005; 187:2426-38.PMID:15774886; DOI:10.1128/ JB.187.7.2426-38.2005.
126. Howden BP, Seemann T, Harrison PF, McEvoy CR, Stanton JA, Rand CJ, et al. Complete genome sequence of Staphylococcus aureus strain JKD6008, an ST239 clone of methicillin-resistant Staphylococcus aureus with intermediate-level vancomycin resistance. J Bacteriol 2010; 192:5848-9.PMID:20802046; DOI:10.1128/JB.00951-10.
127. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.PMID:16517273; DOI:10.1016/S0140- 6736(06)68231-7.
128. Kaushik DK, Sehgal D. Developing antibacterial vaccines in genomics and proteomics era. Scand J Immunol 2008; 67:544-52.PMID:18397199; DOI:10.1111/j.1365-3083.2008.02107.x.
129. Zagursky RJ, Anderson AS. Application of genomics in bacterial vaccine discovery: a decade in review. Curr Opin Pharmacol 2008; 8:632-8.PMID:18625342; DOI:10.1016/j.coph.2008.06.009.
130. Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 2008; 32:71-8.PMID:18757184; DOI:10.1016/j.ijantimicag.2008.06.009.
131. Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, et al. Isolation, structural characterization and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr Res 2003; 338:903-22.PMID:12681914; DOI:10.1016/S0008- 6215(03)00045-4.
132. McKenney D, Hubner J, Muller E, Wang Y, Goldmann DA, Pier GB. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/ adhesin. Infect Immun 1998; 66:4711-20.PMID:9746568.
133. Costa AR, Henriques M, Oliveira R, Azeredo J. The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance. Eur J Clin Microbiol Infect Dis 2009; 28:623-9.PMID:19130107; DOI:10.1007/s10096-008-0684-2.
134. Olson ME, Garvin KL, Fey PD, Rupp ME. Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin Orthop Relat Res 2006; 451:21-4.PMID:16906069; DOI:10.1097/01. blo.0000229320.45416.0c.
135. Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheterassociated infections. J Clin Microbiol 2001; 39:2151-6.PMID:11376050; DOI:10.1128/JCM.39.6.2151-6.2001.
136. Knobloch JK, Horstkotte MA, Rohde H, Mack D. Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Med Microbiol Immunol (Berl) 2002; 191:101-6.PMID:12410349; DOI:10.1007/s00430-002-0124-3.
137. Rohde H, Knobloch JK, Horstkotte MA, Mack D. Correlation of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype. J Clin Microbiol 2001; 39:4595-6. PMID:11797608; DOI:10.1128/ JCM.39.12.4595-6.2001.
138. Ziebuhr W, Heilmann C, Gotz F, Meyer P, Wilms K, Straube E, et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997; 65:890-6.PMID:9038293.
139. Harro JM, Peters BM, O'May GA, Archer N, Kerns P, Prabhakara R, et al. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol 2010; 59:306-23.PMID:20602638.
140. Rappuoli R. Reverse vaccinology. Curr Opin Microbiol 2000; 3:445-50.PMID:11050440; DOI:10.1016/ S1369-5274(00)00119-3.
141. Lowe AM, Beattie DT, Deresiewicz RL. Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol Microbiol 1998; 27:967-76.PMID:9535086; DOI:10.1046/j.1365-2958.1998.00741.x.
142. Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 1998; 30:393-404.PMID:9791183; DOI:10.1046/j.1365- 2958.1998.01075.x.
143. Fountoulakis M, Takacs B. Effect of strong detergents and chaotropes on the detection of proteins in two-dimensional gels. Electrophoresis 2001; 22:1593-602.PMID:11425215; DOI:10.1002/1522-2683(200105)22:9<1593::AIDELPS1593>3.0.CO;2-6.
144. Gatlin CL, Pieper R, Huang ST, Mongodin E, Gebregeorgis E, Parmar PP, et al. Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 2006; 6:1530-49.PMID:16470658; DOI:10.1002/pmic.200500253.
145. Nandakumar R, Nandakumar MP, Marten MR, Ross JM. Proteome analysis of membrane and cell wall associated proteins from Staphylococcus aureus. J Proteome Res 2005; 4:250-7.PMID:15822900; DOI:10.1021/ pr049866k.
146. Musser JM. The next chapter in reverse vaccinology. Nat Biotechnol 2006; 24:157-8.PMID:16465156; DOI:10.1038/nbt0206-157.
147. Rodríguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, et al. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 2006; 24:191-7.PMID:16415855; DOI:10.1038/nbt1179.
148. Solis N, Larsen MR, Cordwell SJ. Improved accuracy of cell surface shaving proteomics in Staphylococcus aureus using a false-positive control. Proteomics 2010; 10:2037-49. PMID:20217865; DOI:10.1002/ pmic.200900564.
149. Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, Huber LA, et al. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2002; 2:580-90.PMID:11987132; DOI:10.1002/1615- 9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G.
150. Glowalla E, Tosetti B, Kronke M, Krut O. Proteomicsbased identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus. Infect Immun 2009; 77:2719-29.PMID:19364833; DOI:10.1128/IAI.00617-08.
151. Chhatwal GS. Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors. Trends Microbiol 2002; 10:205-8.PMID:11973142; DOI:10.1016/S0966-842X(02)02351-X.
152. de Beer D, Stoodley P, Roe F, Lewandowski Z. Effects of biofilm structures on oxygen distribution and mass transport. Biotechnol Bioeng 1994; 43:1131-8.PMID:18615526; DOI:10.1002/bit.260431118.
153. Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988; 22:777-80.PMID:3072331; DOI:10.1093/jac/22.6.777.
154. Mader JTSM. The rabbit model of bacterial osteomyelitis of the tibia. In: Zak OSMA, Ed. In Handbook of Animal Models of Infection London UK: Academic Press Ltd. 1999; 581-91.
155. Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun 2011; 79:1797-803.PMID:21220484; DOI:10.1128/IAI.00451-10.